The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,568,815 in first-year total cost, median $2,784,408.
Most frequent study sections
- Special Emphasis Panel[ZAI1 JA-I (M1)]2
Most frequent institutions
- STANFORD UNIVERSITY1
- VANDERBILT UNIVERSITY MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis1U01AI154659-01 | PHILLIPS, ELIZABETH | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $3,818,815 | ZAI1 |
| 2020 | SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier1U01AI147462-01A1 | BROUGH, HELEN ACHAN, SUSANLACK, GIDEONLEUNG, DONALD YMNADEAU, KARI C. | STANFORD UNIVERSITY, CA | $1,750,000 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.